Skip to main content
Erschienen in: Cancer and Metastasis Reviews 3/2022

30.07.2022

The timing of adiposity and changes in the life course on the risk of cancer

verfasst von: Zhe Fang, Edward L. Giovannucci

Erschienen in: Cancer and Metastasis Reviews | Ausgabe 3/2022

Einloggen, um Zugang zu erhalten

Abstract

Excess body weight has been established as a risk factor for at least twelve cancer sites, though questions remain as to the timing of associations for adiposity and cancer risk throughout the life course. We conducted a narrative review summarizing existing evidence to provide insights into the complex timing relationship between adiposity and risk of seven common obesity-related cancers. We considered five types of studies, including traditional epidemiologic studies examining adiposity at different time points, studies examining weight gain in specific life phases, studies examining weight loss over a period including from bariatric surgery, life course trajectory analysis, and Mendelian randomization studies. The results showed that lifetime excess body weight is associated with increased risk of cancers of endometrium, colorectum, liver, kidney, and pancreas. Early life obesity is one of the strongest risk factors for pancreatic cancer but less directly important than adult obesity for endometrial and kidney cancer. Interestingly, heavy weight during childhood, adolescence, and early adulthood is protective against pre- and postmenopausal breast cancer and possibly advanced prostate cancer. It is apparent that preventing weight gain later in adulthood would likely reduce risk of many cancers, including postmenopausal breast cancer, endometrial cancer, colorectal cancer (especially in men), liver cancer, kidney cancer, and probably advanced prostate cancer. Furthermore, weight loss even late in life may confer benefits for cancers of breast, endometrium, colorectum, and liver among patients with obesity, as mostly demonstrated by studies of bariatric surgery. Overall, maintaining a healthy weight throughout the life course will help prevent a large number of cancers.
Literatur
1.
Zurück zum Zitat World Cancer Research Fund/American Institute for Cancer Research (2018). Body fatness and weight gain and the risk of cancer. Continuous Update Project Expert Report. Available at dietandcancerreport.org. World Cancer Research Fund/American Institute for Cancer Research (2018). Body fatness and weight gain and the risk of cancer. Continuous Update Project Expert Report. Available at dietandcancerreport.org.
11.
Zurück zum Zitat Song, M. (2019). Trajectory analysis in obesity epidemiology: A promising life course approach. Current opinion in endocrine and metabolic research, 4, 37–41.CrossRef Song, M. (2019). Trajectory analysis in obesity epidemiology: A promising life course approach. Current opinion in endocrine and metabolic research, 4, 37–41.CrossRef
17.
18.
Zurück zum Zitat Locke, A. E., Kahali, B., Berndt, S. I., Justice, A. E., Pers, T. H., Day, F. R., et al. (2015). Genetic studies of body mass index yield new insights for obesity biology. Nature, 518(7538), 197–206.CrossRef Locke, A. E., Kahali, B., Berndt, S. I., Justice, A. E., Pers, T. H., Day, F. R., et al. (2015). Genetic studies of body mass index yield new insights for obesity biology. Nature, 518(7538), 197–206.CrossRef
20.
Zurück zum Zitat van den Brandt, P. A., Ziegler, R. G., Wang, M., Hou, T., Li, R., Adami, H. O., et al. (2021). Body size and weight change over adulthood and risk of breast cancer by menopausal and hormone receptor status: A pooled analysis of 20 prospective cohort studies. European Journal of Epidemiology, 36(1), 37–55. https://doi.org/10.1007/s10654-020-00688-3CrossRefPubMed van den Brandt, P. A., Ziegler, R. G., Wang, M., Hou, T., Li, R., Adami, H. O., et al. (2021). Body size and weight change over adulthood and risk of breast cancer by menopausal and hormone receptor status: A pooled analysis of 20 prospective cohort studies. European Journal of Epidemiology, 36(1), 37–55. https://​doi.​org/​10.​1007/​s10654-020-00688-3CrossRefPubMed
30.
Zurück zum Zitat Keum, N., Greenwood, D. C., Lee, D. H., Kim, R., Aune, D., Ju, W., et al. (2015). Adult weight gain and adiposity-related cancers: A dose-response meta-analysis of prospective observational studies. Journal of the National Cancer Institute, 107(2), https://doi.org/10.1093/jnci/djv088. Keum, N., Greenwood, D. C., Lee, D. H., Kim, R., Aune, D., Ju, W., et al. (2015). Adult weight gain and adiposity-related cancers: A dose-response meta-analysis of prospective observational studies. Journal of the National Cancer Institute, 107(2), https://​doi.​org/​10.​1093/​jnci/​djv088.
31.
Zurück zum Zitat Teras, L. R., Patel, A. V., Wang, M., Yaun, S. S., Anderson, K., Brathwaite, R., et al. (2020). Sustained weight loss and risk of breast cancer in women 50 years and older: A pooled analysis of prospective data. Journal of the National Cancer Institute, 112(9), 929–937. https://doi.org/10.1093/jnci/djz226CrossRefPubMed Teras, L. R., Patel, A. V., Wang, M., Yaun, S. S., Anderson, K., Brathwaite, R., et al. (2020). Sustained weight loss and risk of breast cancer in women 50 years and older: A pooled analysis of prospective data. Journal of the National Cancer Institute, 112(9), 929–937. https://​doi.​org/​10.​1093/​jnci/​djz226CrossRefPubMed
35.
Zurück zum Zitat Hao, Y., Xiao, J., Liang, Y., Wu, X., Zhang, H., Xiao, C., et al. (2022). Reassessing the causal role of obesity in breast cancer susceptibility: A comprehensive multivariable Mendelian randomization investigating the distribution and timing of exposure. International Journal of Epidemiology. https://doi.org/10.1093/ije/dyac143CrossRefPubMed Hao, Y., Xiao, J., Liang, Y., Wu, X., Zhang, H., Xiao, C., et al. (2022). Reassessing the causal role of obesity in breast cancer susceptibility: A comprehensive multivariable Mendelian randomization investigating the distribution and timing of exposure. International Journal of Epidemiology. https://​doi.​org/​10.​1093/​ije/​dyac143CrossRefPubMed
37.
Zurück zum Zitat Célind, J., Ohlsson, C., Bygdell, M., Nethander, M., & Kindblom, J. M. (2019). Childhood body mass index is associated with risk of adult colon cancer in men: An association modulated by pubertal change in body mass index. Cancer Epidemiology, Biomarkers & Prevention, 28(5), 974–979. https://doi.org/10.1158/1055-9965.Epi-18-1077CrossRef Célind, J., Ohlsson, C., Bygdell, M., Nethander, M., & Kindblom, J. M. (2019). Childhood body mass index is associated with risk of adult colon cancer in men: An association modulated by pubertal change in body mass index. Cancer Epidemiology, Biomarkers & Prevention, 28(5), 974–979. https://​doi.​org/​10.​1158/​1055-9965.​Epi-18-1077CrossRef
38.
Zurück zum Zitat Garcia, H., & Song, M. (2019). Early-life obesity and adulthood colorectal cancer risk: A meta-analysis. Revista Panamericana de Salud Pública, 43, e3.CrossRef Garcia, H., & Song, M. (2019). Early-life obesity and adulthood colorectal cancer risk: A meta-analysis. Revista Panamericana de Salud Pública, 43, e3.CrossRef
52.
Zurück zum Zitat Carreras-Torres, R., Johansson, M., Gaborieau, V., Haycock, P. C., Wade, K. H., Relton, C. L., et al. (2017). The role of obesity, type 2 diabetes, and metabolic factors in pancreatic cancer: A Mendelian randomization study. Journal of the National Cancer Institute, 109(9), https://doi.org/10.1093/jnci/djx012. Carreras-Torres, R., Johansson, M., Gaborieau, V., Haycock, P. C., Wade, K. H., Relton, C. L., et al. (2017). The role of obesity, type 2 diabetes, and metabolic factors in pancreatic cancer: A Mendelian randomization study. Journal of the National Cancer Institute, 109(9), https://​doi.​org/​10.​1093/​jnci/​djx012.
60.
Zurück zum Zitat Christakoudi, S., Pagoni, P., Ferrari, P., Cross, A. J., Tzoulaki, I., Muller, D. C., et al. (2021). Weight change in middle adulthood and risk of cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort. International Journal of Cancer, 148(7), 1637–1651. https://doi.org/10.1002/ijc.33339CrossRefPubMed Christakoudi, S., Pagoni, P., Ferrari, P., Cross, A. J., Tzoulaki, I., Muller, D. C., et al. (2021). Weight change in middle adulthood and risk of cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort. International Journal of Cancer, 148(7), 1637–1651. https://​doi.​org/​10.​1002/​ijc.​33339CrossRefPubMed
61.
Zurück zum Zitat Chang, S. C., Lacey, J. V., Jr., Brinton, L. A., Hartge, P., Adams, K., Mouw, T., et al. (2007). Lifetime weight history and endometrial cancer risk by type of menopausal hormone use in the NIH-AARP diet and health study. Cancer Epidemiology, Biomarkers & Prevention, 16(4), 723–730. https://doi.org/10.1158/1055-9965.Epi-06-0675CrossRef Chang, S. C., Lacey, J. V., Jr., Brinton, L. A., Hartge, P., Adams, K., Mouw, T., et al. (2007). Lifetime weight history and endometrial cancer risk by type of menopausal hormone use in the NIH-AARP diet and health study. Cancer Epidemiology, Biomarkers & Prevention, 16(4), 723–730. https://​doi.​org/​10.​1158/​1055-9965.​Epi-06-0675CrossRef
64.
Zurück zum Zitat Painter, J. N., O’Mara, T. A., Marquart, L., Webb, P. M., Attia, J., Medland, S. E., et al. (2016). Genetic risk score Mendelian randomization shows that obesity measured as body mass index, but not waist:Hip ratio, is causal for endometrial cancer. Cancer Epidemiology, Biomarkers & Prevention, 25(11), 1503–1510. https://doi.org/10.1158/1055-9965.Epi-16-0147CrossRef Painter, J. N., O’Mara, T. A., Marquart, L., Webb, P. M., Attia, J., Medland, S. E., et al. (2016). Genetic risk score Mendelian randomization shows that obesity measured as body mass index, but not waist:Hip ratio, is causal for endometrial cancer. Cancer Epidemiology, Biomarkers & Prevention, 25(11), 1503–1510. https://​doi.​org/​10.​1158/​1055-9965.​Epi-16-0147CrossRef
66.
Zurück zum Zitat Freuer, D., Linseisen, J., O'Mara, T. A., Leitzmann, M., Baurecht, H., Baumeister, S. E., et al. (2021). Body fat distribution and risk of breast, endometrial, and ovarian cancer: A two-sample Mendelian randomization study. Cancers (Basel), 13(20), https://doi.org/10.3390/cancers13205053. Freuer, D., Linseisen, J., O'Mara, T. A., Leitzmann, M., Baurecht, H., Baumeister, S. E., et al. (2021). Body fat distribution and risk of breast, endometrial, and ovarian cancer: A two-sample Mendelian randomization study. Cancers (Basel), 13(20), https://​doi.​org/​10.​3390/​cancers13205053.
76.
Zurück zum Zitat Sohn, W., Lee, H. W., Lee, S., Lim, J. H., Lee, M. W., Park, C. H., et al. (2021). Obesity and the risk of primary liver cancer: A systematic review and meta-analysis. Clinical and molecular hepatology, 27(1), 157.CrossRef Sohn, W., Lee, H. W., Lee, S., Lim, J. H., Lee, M. W., Park, C. H., et al. (2021). Obesity and the risk of primary liver cancer: A systematic review and meta-analysis. Clinical and molecular hepatology, 27(1), 157.CrossRef
80.
Zurück zum Zitat Ramai, D., Singh, J., Lester, J., Khan, S. R., Chandan, S., Tartaglia, N., et al. (2021). Systematic review with meta-analysis: Bariatric surgery reduces the incidence of hepatocellular carcinoma. Alimentary Pharmacology & Therapeutics, 53(9), 977–984. https://doi.org/10.1111/apt.16335CrossRef Ramai, D., Singh, J., Lester, J., Khan, S. R., Chandan, S., Tartaglia, N., et al. (2021). Systematic review with meta-analysis: Bariatric surgery reduces the incidence of hepatocellular carcinoma. Alimentary Pharmacology & Therapeutics, 53(9), 977–984. https://​doi.​org/​10.​1111/​apt.​16335CrossRef
83.
Zurück zum Zitat Pulit, S. L., Stoneman, C., Morris, A. P., Wood, A. R., Glastonbury, C. A., Tyrrell, J., et al. (2019). Meta-analysis of genome-wide association studies for body fat distribution in 694 649 individuals of European ancestry. Human Molecular Genetics, 28(1), 166–174. https://doi.org/10.1093/hmg/ddy327CrossRefPubMed Pulit, S. L., Stoneman, C., Morris, A. P., Wood, A. R., Glastonbury, C. A., Tyrrell, J., et al. (2019). Meta-analysis of genome-wide association studies for body fat distribution in 694 649 individuals of European ancestry. Human Molecular Genetics, 28(1), 166–174. https://​doi.​org/​10.​1093/​hmg/​ddy327CrossRefPubMed
85.
Zurück zum Zitat Moller, E., Wilson, K. M., Batista, J. L., Mucci, L. A., Balter, K., & Giovannucci, E. (2016). Body size across the life course and prostate cancer in the Health Professionals Follow-up Study. International Journal of Cancer, 138(4), 853–865.CrossRef Moller, E., Wilson, K. M., Batista, J. L., Mucci, L. A., Balter, K., & Giovannucci, E. (2016). Body size across the life course and prostate cancer in the Health Professionals Follow-up Study. International Journal of Cancer, 138(4), 853–865.CrossRef
87.
Zurück zum Zitat Genkinger, J. M., Wu, K., Wang, M., Albanes, D., Black, A., van den Brandt, P. A., et al. (2020). Measures of body fatness and height in early and mid-to-late adulthood and prostate cancer: Risk and mortality in The Pooling Project of Prospective Studies of Diet and Cancer. Annals of Oncology, 31(1), 103–114.CrossRef Genkinger, J. M., Wu, K., Wang, M., Albanes, D., Black, A., van den Brandt, P. A., et al. (2020). Measures of body fatness and height in early and mid-to-late adulthood and prostate cancer: Risk and mortality in The Pooling Project of Prospective Studies of Diet and Cancer. Annals of Oncology, 31(1), 103–114.CrossRef
88.
Zurück zum Zitat Harrison, S., Tilling, K., Turner, E. L., Martin, R. M., Lennon, R., Lane, J. A., et al. (2020). Systematic review and meta-analysis of the associations between body mass index, prostate cancer, advanced prostate cancer, and prostate-specific antigen. Cancer Causes and Control, 31(5), 431–449.CrossRef Harrison, S., Tilling, K., Turner, E. L., Martin, R. M., Lennon, R., Lane, J. A., et al. (2020). Systematic review and meta-analysis of the associations between body mass index, prostate cancer, advanced prostate cancer, and prostate-specific antigen. Cancer Causes and Control, 31(5), 431–449.CrossRef
91.
Zurück zum Zitat Kelly, S. P., Lennon, H., Sperrin, M., Matthews, C., Freedman, N. D., Albanes, D., et al. (2019). Body mass index trajectories across adulthood and smoking in relation to prostate cancer risks: The NIH-AARP diet and health study. International Journal of Epidemiology, 48(2), 464–473.CrossRef Kelly, S. P., Lennon, H., Sperrin, M., Matthews, C., Freedman, N. D., Albanes, D., et al. (2019). Body mass index trajectories across adulthood and smoking in relation to prostate cancer risks: The NIH-AARP diet and health study. International Journal of Epidemiology, 48(2), 464–473.CrossRef
92.
Zurück zum Zitat Lavalette, C., Duverger, E. C., Artaud, F., Rebillard, X., Lamy, P. J., Tretarre, B., et al. (2020). Body mass index trajectories and prostate cancer risk: results from the EPICAP study. Cancer Medecine. Lavalette, C., Duverger, E. C., Artaud, F., Rebillard, X., Lamy, P. J., Tretarre, B., et al. (2020). Body mass index trajectories and prostate cancer risk: results from the EPICAP study. Cancer Medecine.
93.
Zurück zum Zitat Keum, N., Greenwood, D. C., Lee, D. H., Kim, R., Aune, D., Ju, W., et al. (2015). Adult weight gain and adiposity-related cancers: A dose-response meta-analysis of prospective observational studies. Journal of the National Cancer Institute, 107(2), djv088.CrossRef Keum, N., Greenwood, D. C., Lee, D. H., Kim, R., Aune, D., Ju, W., et al. (2015). Adult weight gain and adiposity-related cancers: A dose-response meta-analysis of prospective observational studies. Journal of the National Cancer Institute, 107(2), djv088.CrossRef
94.
Zurück zum Zitat Dickerman, B. A., Ahearn, T. U., Giovannucci, E., Stampfer, M. J., Nguyen, P. L., Mucci, L. A., et al. (2017). Weight change, obesity and risk of prostate cancer progression among men with clinically localized prostate cancer. International Journal of Cancer, 141(5), 933–944.CrossRef Dickerman, B. A., Ahearn, T. U., Giovannucci, E., Stampfer, M. J., Nguyen, P. L., Mucci, L. A., et al. (2017). Weight change, obesity and risk of prostate cancer progression among men with clinically localized prostate cancer. International Journal of Cancer, 141(5), 933–944.CrossRef
96.
Zurück zum Zitat Davies, N. M., Gaunt, T. R., Lewis, S. J., Holly, J., Donovan, J. L., Hamdy, F. C., et al. (2015). The effects of height and BMI on prostate cancer incidence and mortality: A Mendelian randomization study in 20,848 cases and 20,214 controls from the PRACTICAL consortium. Cancer Causes and Control, 26(11), 1603–1616. https://doi.org/10.1007/s10552-015-0654-9CrossRefPubMed Davies, N. M., Gaunt, T. R., Lewis, S. J., Holly, J., Donovan, J. L., Hamdy, F. C., et al. (2015). The effects of height and BMI on prostate cancer incidence and mortality: A Mendelian randomization study in 20,848 cases and 20,214 controls from the PRACTICAL consortium. Cancer Causes and Control, 26(11), 1603–1616. https://​doi.​org/​10.​1007/​s10552-015-0654-9CrossRefPubMed
101.
105.
Zurück zum Zitat Lee, J. S., Lee, H. S., Ha, J. S., Han, K. S., Rha, K. H., Hong, S. J., et al. (2018). Subcutaneous fat distribution is a prognostic biomarker for men with castration resistant prostate cancer. Journal of Urology, 200(1), 114–120.CrossRef Lee, J. S., Lee, H. S., Ha, J. S., Han, K. S., Rha, K. H., Hong, S. J., et al. (2018). Subcutaneous fat distribution is a prognostic biomarker for men with castration resistant prostate cancer. Journal of Urology, 200(1), 114–120.CrossRef
106.
Zurück zum Zitat Florio, A. A., Campbell, P. T., Zhang, X., Zeleniuch-Jacquotte, A., Wactawski-Wende, J., Smith-Warner, S. A., et al. (2020). Abdominal and gluteofemoral size and risk of liver cancer: The liver cancer pooling project. International Journal of Cancer, 147(3), 675–685. https://doi.org/10.1002/ijc.32760CrossRefPubMed Florio, A. A., Campbell, P. T., Zhang, X., Zeleniuch-Jacquotte, A., Wactawski-Wende, J., Smith-Warner, S. A., et al. (2020). Abdominal and gluteofemoral size and risk of liver cancer: The liver cancer pooling project. International Journal of Cancer, 147(3), 675–685. https://​doi.​org/​10.​1002/​ijc.​32760CrossRefPubMed
Metadaten
Titel
The timing of adiposity and changes in the life course on the risk of cancer
verfasst von
Zhe Fang
Edward L. Giovannucci
Publikationsdatum
30.07.2022
Verlag
Springer US
Erschienen in
Cancer and Metastasis Reviews / Ausgabe 3/2022
Print ISSN: 0167-7659
Elektronische ISSN: 1573-7233
DOI
https://doi.org/10.1007/s10555-022-10054-2

Weitere Artikel der Ausgabe 3/2022

Cancer and Metastasis Reviews 3/2022 Zur Ausgabe

EditorialNotes

Preface

Erhebliches Risiko für Kehlkopfkrebs bei mäßiger Dysplasie

29.05.2024 Larynxkarzinom Nachrichten

Fast ein Viertel der Personen mit mäßig dysplastischen Stimmlippenläsionen entwickelt einen Kehlkopftumor. Solche Personen benötigen daher eine besonders enge ärztliche Überwachung.

15% bedauern gewählte Blasenkrebs-Therapie

29.05.2024 Urothelkarzinom Nachrichten

Ob Patienten und Patientinnen mit neu diagnostiziertem Blasenkrebs ein Jahr später Bedauern über die Therapieentscheidung empfinden, wird einer Studie aus England zufolge von der Radikalität und dem Erfolg des Eingriffs beeinflusst.

Erhöhtes Risiko fürs Herz unter Checkpointhemmer-Therapie

28.05.2024 Nebenwirkungen der Krebstherapie Nachrichten

Kardiotoxische Nebenwirkungen einer Therapie mit Immuncheckpointhemmern mögen selten sein – wenn sie aber auftreten, wird es für Patienten oft lebensgefährlich. Voruntersuchung und Monitoring sind daher obligat.

Costims – das nächste heiße Ding in der Krebstherapie?

28.05.2024 Onkologische Immuntherapie Nachrichten

„Kalte“ Tumoren werden heiß – CD28-kostimulatorische Antikörper sollen dies ermöglichen. Am besten könnten diese in Kombination mit BiTEs und Checkpointhemmern wirken. Erste klinische Studien laufen bereits.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.